SEC Form 4 · accession 0001596771-18-000038
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Rice
Officer — EVP of Operations
Period of report
Mar 27, 2018
Accepted (ET)
Mar 29, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 27, 2018 | A | 3,778 | $0.00 | A | 8,365 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF2 | $20.52 | Mar 27, 2018 | A | 8,980 | A | — | Mar 27, 2028 | Common Stock | 8,980 | 8,980 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") were granted in connection with the Issuer's equity incentive plan. One-third of the RSUs will vest on each of the first, second and third anniversary of the grant date.
- F2The options were granted in connection with the Issuer's equity incentive plan. One-third of the options will vest on each of the first, second and third anniversary of the grant date.